Categories AlphaGraphs, Earnings, Health Care

Cigna Group (CI) reports double-digit revenue growth for Q1; guides FY24

The Cigna Group (NYSE: CI), a healthcare company focused on medical insurance and related services, Thursday reported a sharp increase in revenues for the first quarter of 2024.

Cigna Q1 2024 earnings infographic

First-quarter revenues climbed 23% annually to $57.3 billion, mainly reflecting a 31% revenue growth in the core Pharmacy segment. For fiscal 2024, the management expects revenues to be approximately $235 billion, on an adjusted basis.

Adjusted operating income, on a per-share basis, rose 20% year-over-year to $6.47 in Q1. For the full fiscal year, Cigna is looking for an adjusted operating profit of around $8.07 billion.

Meanwhile, the company reported a shareholders’ net loss of $277 million or $0.97 per share for the March quarter, compared to a profit of $1.27 billion or $4.24 per share in the year-ago quarter.

Prior Performance

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q2 2024 financial results

Colgate-Palmolive Company (NYSE: CL) reported its second quarter 2024 earnings results today. Net sales increased 4.9% year-over-year to $5 billion. Organic sales increased 9%. Net income attributable to Colgate-Palmolive Company was $731

Key takeaways from Visa’s Q3 2024 earnings report

Credit card behemoth Visa, Inc. (NYSE: V) this week reported mixed results for the June quarter, with earnings matching expectations and sales slightly missing the view. Both numbers grew in

Southwest Airlines (LUV): A look at the airline’s performance in Q2 2024

Shares of Southwest Airlines Co. (NYSE: LUV) were up over 6% on Thursday after the company beat earnings estimates for the second quarter of 2024. The stock has gained 4%

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top